Product Information

SEVELAMER HCL 800 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.7740 per EA under NDC 70710205808. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Feb 3, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SEVELAMER HCL 800 MG TABLET

Sevelamer Hydrochloride
$0.7740per EA

Strength

800 mg/1

NDC

70710205808

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SEVELAMER HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218966

FDA Approved

2/3/2025

TE Code

AB

On Market Since

3/1/2025

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for SEVELAMER HCL 800 MG TABLET has been published 76 times since Jun 11, 2025, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7740 per EA
All-time high$1.3679 (Sep 10, 2025)
All-time low$0.6842 (Oct 21, 2026)
52-week high$1.1940
52-week low$0.6842
Median price$0.9464
Average price$0.9910
Largest weekly change+13.1% (Nov 18, 2026)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

+13.1%

1M

+11.3%

3M

+10.2%

6M

+0.1%

1Y

-42.6%

3Y

N/A

5Y

N/A

All

-32.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SEVELAMER HCL 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.7740 per EA (NDC 70710205808), effective Nov 18, 2026.

How has the price of SEVELAMER HCL 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 32.5%. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?

Since Jun 11, 2025, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.6842 (Oct 21, 2026) to a high of $1.3679 (Sep 10, 2025), with a median of $0.9464 per EA.

Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SEVELAMER HCL 800 MG TABLET, is $0.7735 per EA — about 0% below SEVELAMER HCL 800 MG TABLET.

Who manufactures SEVELAMER HCL 800 MG TABLET?

SEVELAMER HCL 800 MG TABLET (NDC 70710205808) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.